ONWARD MEDICAL (ONWD.BR) Stock Fundamental Analysis

EBR:ONWD • NL0015000HT4

4.1 EUR
-0.09 (-2.15%)
Last: Feb 12, 2026, 07:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ONWD. ONWD was compared to 63 industry peers in the Health Care Equipment & Supplies industry. ONWD scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. While showing a medium growth rate, ONWD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ONWD had negative earnings in the past year.
  • ONWD had a negative operating cash flow in the past year.
  • ONWD had negative earnings in each of the past 5 years.
  • In the past 5 years ONWD always reported negative operating cash flow.
ONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFONWD.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

  • With a Return On Assets value of -67.68%, ONWD is not doing good in the industry: 88.89% of the companies in the same industry are doing better.
  • ONWD has a Return On Equity of -137.73%. This is amonst the worse of the industry: ONWD underperforms 82.54% of its industry peers.
Industry RankSector Rank
ROA -67.68%
ROE -137.73%
ROIC N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ONWD.BR Yearly ROA, ROE, ROICONWD.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150 -200

1.3 Margins

  • ONWD has a Gross Margin of 77.16%. This is amongst the best in the industry. ONWD outperforms 88.89% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ONWD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ONWD.BR Yearly Profit, Operating, Gross MarginsONWD.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 -10K -20K -30K -40K -50K

4

2. Health

2.1 Basic Checks

  • ONWD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, ONWD has more shares outstanding
  • ONWD has more shares outstanding than it did 5 years ago.
  • ONWD has a better debt/assets ratio than last year.
ONWD.BR Yearly Shares OutstandingONWD.BR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
ONWD.BR Yearly Total Debt VS Total AssetsONWD.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

  • Based on the Altman-Z score of -1.28, we must say that ONWD is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -1.28, ONWD is doing worse than 79.37% of the companies in the same industry.
  • A Debt/Equity ratio of 0.52 indicates that ONWD is somewhat dependend on debt financing.
  • ONWD has a Debt to Equity ratio of 0.52. This is comparable to the rest of the industry: ONWD outperforms 42.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -1.28
ROIC/WACCN/A
WACC7.48%
ONWD.BR Yearly LT Debt VS Equity VS FCFONWD.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

2.3 Liquidity

  • A Current Ratio of 4.34 indicates that ONWD has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 4.34, ONWD belongs to the top of the industry, outperforming 93.65% of the companies in the same industry.
  • ONWD has a Quick Ratio of 4.30. This indicates that ONWD is financially healthy and has no problem in meeting its short term obligations.
  • ONWD's Quick ratio of 4.30 is amongst the best of the industry. ONWD outperforms 98.41% of its industry peers.
Industry RankSector Rank
Current Ratio 4.34
Quick Ratio 4.3
ONWD.BR Yearly Current Assets VS Current LiabilitesONWD.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 20.69% over the past year.
  • Looking at the last year, ONWD shows a very strong growth in Revenue. The Revenue has grown by 236.76%.
EPS 1Y (TTM)20.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.47%
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 12.03% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 148.02% on average over the next years. This is a very strong growth
EPS Next Y8.5%
EPS Next 2Y5.76%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year354.68%
Revenue Next 2Y277.45%
Revenue Next 3Y246.87%
Revenue Next 5Y148.02%

3.3 Evolution

ONWD.BR Yearly Revenue VS EstimatesONWD.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
ONWD.BR Yearly EPS VS EstimatesONWD.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

0

4. Valuation

4.1 Price/Earnings Ratio

  • ONWD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ONWD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ONWD.BR Price Earnings VS Forward Price EarningsONWD.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ONWD.BR Per share dataONWD.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

  • ONWD's earnings are expected to grow with 12.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y5.76%
EPS Next 3Y12.03%

0

5. Dividend

5.1 Amount

  • ONWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ONWARD MEDICAL

EBR:ONWD (2/12/2026, 7:00:00 PM)

4.1

-0.09 (-2.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-24
Earnings (Next)03-30
Inst Owners22.58%
Inst Owner ChangeN/A
Ins Owners12.81%
Ins Owner ChangeN/A
Market Cap229.64M
Revenue(TTM)1.11M
Net Income(TTM)-38.18M
Analysts87.27
Price Target10.42 (154.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.67%
PT rev (3m)-17.45%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-5.15%
EPS NY rev (3m)21.66%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-13.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 206.51
P/FCF N/A
P/OCF N/A
P/B 8.28
P/tB 12.43
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)-0.8
Fwd EYN/A
FCF(TTM)-0.64
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0.02
BVpS0.49
TBVpS0.33
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -67.68%
ROE -137.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.16%
FCFM N/A
ROA(3y)-57.55%
ROA(5y)-69.28%
ROE(3y)-112.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 37.34%
Cap/Sales 31.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.34
Quick Ratio 4.3
Altman-Z -1.28
F-Score6
WACC7.48%
ROIC/WACCN/A
Cap/Depr(3y)43.86%
Cap/Depr(5y)180.36%
Cap/Sales(3y)362.35%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10.47%
EPS Next Y8.5%
EPS Next 2Y5.76%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)236.76%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year354.68%
Revenue Next 2Y277.45%
Revenue Next 3Y246.87%
Revenue Next 5Y148.02%
EBIT growth 1Y0.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-23.76%
EBIT Next 3Y6.38%
EBIT Next 5YN/A
FCF growth 1Y-9.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.94%
OCF growth 3YN/A
OCF growth 5YN/A

ONWARD MEDICAL / ONWD.BR FAQ

Can you provide the ChartMill fundamental rating for ONWARD MEDICAL?

ChartMill assigns a fundamental rating of 2 / 10 to ONWD.BR.


What is the valuation status of ONWARD MEDICAL (ONWD.BR) stock?

ChartMill assigns a valuation rating of 0 / 10 to ONWARD MEDICAL (ONWD.BR). This can be considered as Overvalued.


What is the profitability of ONWD stock?

ONWARD MEDICAL (ONWD.BR) has a profitability rating of 1 / 10.


Can you provide the financial health for ONWD stock?

The financial health rating of ONWARD MEDICAL (ONWD.BR) is 4 / 10.


Can you provide the expected EPS growth for ONWD stock?

The Earnings per Share (EPS) of ONWARD MEDICAL (ONWD.BR) is expected to grow by 8.5% in the next year.